PREDICATE trial for serious lung infections
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new approach to treating serious respiratory infections in hospitalized adults. It aims to see if a targeted strategy works better than standard care while avoiding extra risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and need to be admitted to the hospital for a serious lung or airway infection.
- You are not pregnant, a prisoner, or unable to give consent.
- You are not currently on active cancer treatment, immune-suppressing drugs, or long-term antibiotics or steroids.
- You have not had major surgery in the last month, and you do not have advanced kidney disease or other severe chronic illnesses that limit your life expectancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This trial tests a new approach to treating respiratory infections in adults who are at higher risk of becoming seriously ill but can still be treated in an outpatient clinic. It aims to see if this approach helps prevent severe disease.
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
Hear when a new Respiratory Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.